A citation-based method for searching scientific literature

Darrell J Irvine, Eric L Dane. Nat Rev Immunol 2020
Times Cited: 129







List of co-cited articles
1134 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Delivery technologies for cancer immunotherapy.
Rachel S Riley, Carl H June, Robert Langer, Michael J Mitchell. Nat Rev Drug Discov 2019
469
23

Cancer nanomedicine: progress, challenges and opportunities.
Jinjun Shi, Philip W Kantoff, Richard Wooster, Omid C Farokhzad. Nat Rev Cancer 2017
23

Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges.
John D Martin, Horacio Cabral, Triantafyllos Stylianopoulos, Rakesh K Jain. Nat Rev Clin Oncol 2020
106
20

Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.
Saeid Zanganeh, Gregor Hutter, Ryan Spitler, Olga Lenkov, Morteza Mahmoudi, Aubie Shaw, Jukka Sakari Pajarinen, Hossein Nejadnik, Stuart Goodman, Michael Moseley,[...]. Nat Nanotechnol 2016
550
16

Smart cancer nanomedicine.
Roy van der Meel, Einar Sulheim, Yang Shi, Fabian Kiessling, Willem J M Mulder, Twan Lammers. Nat Nanotechnol 2019
235
15

Combining Nanomedicine and Immunotherapy.
Yang Shi, Twan Lammers. Acc Chem Res 2019
96
15

Improving cancer immunotherapy through nanotechnology.
Michael S Goldberg. Nat Rev Cancer 2019
155
15

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery.
Li Tang, Yiran Zheng, Mariane Bandeira Melo, Llian Mabardi, Ana P Castaño, Yu-Qing Xie, Na Li, Sagar B Kudchodkar, Hing C Wong, Emily K Jeng,[...]. Nat Biotechnol 2018
180
15

Understanding the tumor immune microenvironment (TIME) for effective therapy.
Mikhail Binnewies, Edward W Roberts, Kelly Kersten, Vincent Chan, Douglas F Fearon, Miriam Merad, Lisa M Coussens, Dmitry I Gabrilovich, Suzanne Ostrand-Rosenberg, Catherine C Hedrick,[...]. Nat Med 2018
14

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.
Christopher B Rodell, Sean P Arlauckas, Michael F Cuccarese, Christopher S Garris, Ran Li, Maaz S Ahmed, Rainer H Kohler, Mikael J Pittet, Ralph Weissleder. Nat Biomed Eng 2018
303
13

The entry of nanoparticles into solid tumours.
Shrey Sindhwani, Abdullah Muhammad Syed, Jessica Ngai, Benjamin R Kingston, Laura Maiorino, Jeremy Rothschild, Presley MacMillan, Yuwei Zhang, Netra Unni Rajesh, Tran Hoang,[...]. Nat Mater 2020
336
13

Cancer immunotherapy using checkpoint blockade.
Antoni Ribas, Jedd D Wolchok. Science 2018
12

T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity.
Daniela Schmid, Chun Gwon Park, Christina A Hartl, Nikita Subedi, Adam N Cartwright, Regina Bou Puerto, Yiran Zheng, James Maiarana, Gordon J Freeman, Kai W Wucherpfennig,[...]. Nat Commun 2017
160
12

Designer vaccine nanodiscs for personalized cancer immunotherapy.
Rui Kuai, Lukasz J Ochyl, Keith S Bahjat, Anna Schwendeman, James J Moon. Nat Mater 2017
406
11



Principles of nanoparticle design for overcoming biological barriers to drug delivery.
Elvin Blanco, Haifa Shen, Mauro Ferrari. Nat Biotechnol 2015
11


Nanoparticles in the clinic: An update.
Aaron C Anselmo, Samir Mitragotri. Bioeng Transl Med 2019
293
10

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.
Yuanzeng Min, Kyle C Roche, Shaomin Tian, Michael J Eblan, Karen P McKinnon, Joseph M Caster, Shengjie Chai, Laura E Herring, Longzhen Zhang, Tian Zhang,[...]. Nat Nanotechnol 2017
261
9

Stimuli-responsive nanocarriers for drug delivery.
Simona Mura, Julien Nicolas, Patrick Couvreur. Nat Mater 2013
9


Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.
Xiaopin Duan, Christina Chan, Wenbin Lin. Angew Chem Int Ed Engl 2019
197
9

Immunogenic cell death and DAMPs in cancer therapy.
Dmitri V Krysko, Abhishek D Garg, Agnieszka Kaczmarek, Olga Krysko, Patrizia Agostinis, Peter Vandenabeele. Nat Rev Cancer 2012
881
9

Oncology meets immunology: the cancer-immunity cycle.
Daniel S Chen, Ira Mellman. Immunity 2013
9

In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment.
Qian Chen, Chao Wang, Xudong Zhang, Guojun Chen, Quanyin Hu, Hongjun Li, Jinqiang Wang, Di Wen, Yuqi Zhang, Yifei Lu,[...]. Nat Nanotechnol 2019
242
9

A STING-activating nanovaccine for cancer immunotherapy.
Min Luo, Hua Wang, Zhaohui Wang, Haocheng Cai, Zhigang Lu, Yang Li, Mingjian Du, Gang Huang, Chensu Wang, Xiang Chen,[...]. Nat Nanotechnol 2017
281
9

Cancer immunotherapy comes of age.
Ira Mellman, George Coukos, Glenn Dranoff. Nature 2011
9

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.
Michael A Postow, Robert Sidlow, Matthew D Hellmann. N Engl J Med 2018
8


Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
8

Challenges and strategies in anti-cancer nanomedicine development: An industry perspective.
Jennifer I Hare, Twan Lammers, Marianne B Ashford, Sanyogitta Puri, Gert Storm, Simon T Barry. Adv Drug Deliv Rev 2017
462
8

Doxil®--the first FDA-approved nano-drug: lessons learned.
Yechezkel Barenholz. J Control Release 2012
8

Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy.
Jason Park, Stephen H Wrzesinski, Eric Stern, Michael Look, Jason Criscione, Ragy Ragheb, Steven M Jay, Stacey L Demento, Atu Agawu, Paula Licona Limon,[...]. Nat Mater 2012
282
8

Exploiting lymphatic transport and complement activation in nanoparticle vaccines.
Sai T Reddy, André J van der Vlies, Eleonora Simeoni, Veronique Angeli, Gwendalyn J Randolph, Conlin P O'Neil, Leslie K Lee, Melody A Swartz, Jeffrey A Hubbell. Nat Biotechnol 2007
768
8

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles.
Matthias T Stephan, James J Moon, Soong Ho Um, Anna Bershteyn, Darrell J Irvine. Nat Med 2010
373
8

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.
Daniel Bobo, Kye J Robinson, Jiaul Islam, Kristofer J Thurecht, Simon R Corrie. Pharm Res 2016
915
8

Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells.
Bonnie Huang, Wuhbet D Abraham, Yiran Zheng, Sandra C Bustamante López, Samantha S Luo, Darrell J Irvine. Sci Transl Med 2015
142
8

Organic Semiconducting Pro-nanostimulants for Near-Infrared Photoactivatable Cancer Immunotherapy.
Jingchao Li, Dong Cui, Jiaguo Huang, Shasha He, Zebin Yang, Yan Zhang, Yu Luo, Kanyi Pu. Angew Chem Int Ed Engl 2019
110
7

Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.
Qian Chen, Jiawen Chen, Zhijuan Yang, Jun Xu, Ligeng Xu, Chao Liang, Xiao Han, Zhuang Liu. Adv Mater 2019
167
7

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
7

Immunogenic cell death in cancer therapy.
Guido Kroemer, Lorenzo Galluzzi, Oliver Kepp, Laurence Zitvogel. Annu Rev Immunol 2013
7

Immunogenic cell death in cancer and infectious disease.
Lorenzo Galluzzi, Aitziber Buqué, Oliver Kepp, Laurence Zitvogel, Guido Kroemer. Nat Rev Immunol 2017
987
7

Tumour-associated macrophages as treatment targets in oncology.
Alberto Mantovani, Federica Marchesi, Alberto Malesci, Luigi Laghi, Paola Allavena. Nat Rev Clin Oncol 2017
7

Tailoring Nanomaterials for Targeting Tumor-Associated Macrophages.
Muhammad Ovais, Mengyu Guo, Chunying Chen. Adv Mater 2019
82
8

In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.
Tyrel T Smith, Sirkka B Stephan, Howell F Moffett, Laura E McKnight, Weihang Ji, Diana Reiman, Emmy Bonagofski, Martin E Wohlfahrt, Smitha P S Pillai, Matthias T Stephan. Nat Nanotechnol 2017
227
7

Structure-based programming of lymph-node targeting in molecular vaccines.
Haipeng Liu, Kelly D Moynihan, Yiran Zheng, Gregory L Szeto, Adrienne V Li, Bonnie Huang, Debra S Van Egeren, Clara Park, Darrell J Irvine. Nature 2014
442
7

Cellular backpacks for macrophage immunotherapy.
C Wyatt Shields, Michael A Evans, Lily Li-Wen Wang, Neil Baugh, Siddharth Iyer, Debra Wu, Zongmin Zhao, Anusha Pusuluri, Anvay Ukidve, Daniel C Pan,[...]. Sci Adv 2020
58
12

Cytokines in clinical cancer immunotherapy.
Pedro Berraondo, Miguel F Sanmamed, María C Ochoa, Iñaki Etxeberria, Maria A Aznar, José Luis Pérez-Gracia, María E Rodríguez-Ruiz, Mariano Ponz-Sarvise, Eduardo Castañón, Ignacio Melero. Br J Cancer 2019
209
7



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.